Propofol infusion syndrome pris is a rare syndrome which affects patients undergoing longterm treatment with high doses of the anaesthetic and sedative drug propofol. Pris occurs mostly in the setting of prolonged and highdose propofol infusion administration in children. One serious adverse event is propofolrelated infusion syndrome or propofol infusion syndrome pris, a constellation of signs and symptoms, including bradycardia, metabolic acidosis, liver. Acute central nervous system disease, sepsis, burns, pancreatitis, trauma, and status asthmaticus have been identified as priming factor disease states. The term prispropofol infusion syndromewas originally coined by bray in 1998 to describe the adverse effects associated with the use of propofol in the paediatric population.
Most frequent with prolonged, highdose infusions 5 mgkghr for 48 hr but has also been reported following largedose, shortterm infusions during surgical anesthesia. Certain risk factors for the development of propofol infusion syndrome are described, such as appropriate propofol doses and durations of administration. This potentially lethal metabolic derangement has been reported in critically ill patients after a prolonged infusion of highdose substance in combination with catecholamines andor corticosteroids. Propofol related infusion syndrome pris presents as acute metabolic acidosis and cardiac dysfunction in combination with one or more of the following features.
Furthermore, the ever sohelpful astra zeneca people have a pi document in pdf for you to read. Propofol infusion syndrome is a rare but extremely dangerous complication of propofol administration. I have some ethical concerns about a prospective trial of propofol infusions in children. Furthermore, a causal relation between propofol anesthesia and the syndrome has never been established. Propofol infusion syndrome pris is a rare but potentially lethal complication after longterm, highdose propofol infusion. Propofol 2,6diisopropylphenol, an intravenous sedativehypnotic approved by the fda for the induction and maintenance of sedation and anesthesia, is one of the most commonly utilized medications in the icu setting secondary to its antiepileptic and neuroprotective properties. Propofol infusion syndrome british journal of anaesthesia. Propofol intolerance refers to propofol infusion syndrome, hemodynamic instability precluding propofol use, elevated creatinine phosphokinase cpk. Propofolrelated infusion syndrome continued from page 20 this may also partially explain some of the cardiac symptoms described in some of the case reports. Propofol infusion syndrome pris is a rare, but potentially lethal adverse effect of a commonly used drug. It suggests that propofol infusion syndrome is in fact due to propofol or a propofol metabolite, is reversible in its early stages, and is consistent with previous cautions to avoid highdose, prolonged infusions of propofol. Propofol is a commonly used sedative agent in icu due to its rapid onset of action and recovery. Propofol is one of the most commonly used agents by anesthesia providers.
On the other hand, longer infusions and higher doses of propofol may precipitate the propofol infusion syndrome. The propofol infusion syndrome severe metabolic acidosis, rhabdomyolysis, hyperkalemia, renal failure, and cardiovascular. Propofol infusion syndrome is well covered by kam yes, that kam propofol chemical structure 2,6 diisopropylphenol is an alkylphenol. Propofol infusion syndrome is a rare but extremely deleterious consequence of propofol administratioa motor evoked potentials are the most popular method to monitor the functional integrity of the. Apr 12, 2015 propofol infusion syndrome is a rare but extremely dangerous complication of propofol administration. Loh and others published propofol infusion syndrome find, read and cite all the research you need on researchgate. Despite its excellent safety profile, numerous drawbacks and patient safety issues remain. Both barbiturates and propofol may exacerbate hemodynamic problems in unstable patients.
The timing of these arrhythmias and hypotension is unusual in our case, as these are usually late manifestations of propofol infusion syndrome. Metabolic acidosis associated with propofol in the absence of. Since lipid emulsion is the solvent and excipient for propofol, questions arise on whether the impaired ffa metabolism is a result of propofol itself or the lipid emulsion. Propofol infusion syndrome is a rare, potentially fatal condition first described in children in the 1990s and later reported. It can lead to cardiac failure, rhabdomyolysis, metabolic acidosis, and kidney failure, and is often fatal. We searched for all case reports published between 1990 and.
Propofol infusion syndrome pris is a rare and often fatal syndrome described in critically ill children undergoing longterm propofol infusion at high doses. Propofol infusion syndrome kam 2007 anaesthesia wiley. The term pris propofol infusion syndrome was originally coined by bray in 1998 to describe the adverse effects associated with the use of propofol in the paediatric population. Pris was defined as acute refractory bradycardia leading to asystole in the presence of one or more of the following. We analysed the relationship between signs of pris and the rate and. It appears to develop in the context of highdose, prolonged propofol 100. Propofol infusion syndrome bja education oxford academic. Propofol infusion syndrome definition of propofol infusion. See what are side effects associated with using propofol. The three newcastle children who developed the syndrome and died were not treated in the intensivecare unit in which i work. Propofol infusion syndrome pris is defined as acute bradycardia progressing to asystole combined with lipemic plasma, fatty liver enlargement, metabolic. Sedation during medical procedures poses a risk to any patient, and the use of specific anesthetic agents should be carefully considered to avoid adverse outcomes. The figure below illustrates the fall of plasma propofol levels following infusions of various durations to provide icu sedation.
Propofol infusion syndrome is a rare, potentially fatal condition first described in children in the 1990s and later reported in adults. We searched for all case reports published between 1990 and 2014 and for all experimental studies on pris pathophysiology. Both barbiturates and propofol may exacerbate hemodynamic problems. Recently several cases have been reported in adults, too. Propofolrelated infusion syndrome pris presents as acute metabolic acidosis and cardiac dysfunction in combination with one or more of the following features. Propofol infusion syndrome pris is defined as acute bradycardia progressing to asystole combined with lipemic plasma, fatty liver enlargement, metabolic acidosis with negative base excess 10. The suggestion that the propofol syndrome may occur in the context of single bolus administration or shortterm infusion in children is incorrect. A 58yearold female on chronic hemodialysis due to end stage kidney disease secondary to microscopic. Pris is characterized by a multiorgan failure, rhabdomyolysis. A prospective cohort study in 2009 for 1,017 critically ill patients found an incidence of 1. Propofol infusion syndrome is a rare syndrome typically occurring after over 48 hours of propofol infusions at greater rates than 4 mgkghr 67 ucgkgmin. Jun 12, 2007 although previous reports have described severe metabolic acidosis during propofol infusion in children, cases have been described in adult patients more recently 3, 4, 68, 10, 23.
Propofol infusion syndrome an overview sciencedirect topics. It has been described only with acute neurologic injury or acute inflammatory diseases complicated by severe infections or sepsis. Propofol infusion syndrome in the postoperative period of a. Review article propofol infusion syndrome in adults. The main features of the syndrome consist of cardiac failure, rhabdomyolysis, severe metabolic acidosis and renal failure. With great interest, we read about the reports of death by wysowski and pollock1 regarding the use of propofol for longterm sedation in pediatric and adult patients. The safe dose of propofol infusion for sedation in intensive care is considered to be 14 mg kg. One of its rare but lethal complication is propofol infusion syndrome pris which is characterized by severe metabolic acidosis, rhabdomyolysis, acute renal failure, refractory arrhythmias, myocardial failure, hepatic dysfunction and hyperlipidemia.
We report on a patient with propofol infusion syndrome diagnosed during the postoperative period of a renal transplant. Certain risk factors for the development of propofol infusion syndrome are described, such as appropriate propofol doses and durations of. However, propofol is not without adverse effects, such as pain on injection, apnea, and hypotension. It is commonly used as sedation, as well as an anesthetic agent in both pediatric and adult patient populations. Although we agree that further study is needed to look into the use of propofol in this setting, many clinicians believe it is appropriate to continue propofol use in paediatric intensive care. Propofol infusion syndrome pris is a rare, but potentially lethal. Refractory bradycardia and cardiovascular collapse. The syndrome is characterized by severe metabolic acidosis, hyperkalemia, lipemia. Icu sedation protocol for ventilated patients last modified. If, however, higher than necessary infusion levels have been maintained for a long time, propofol redistribution from fat and muscle to the plasma can be significant and slow recovery. There have been numerous case reports describing a constellation of findings including metabolic derangements and organ system failures known collectively as propofol infusion syndrome pris. Propofol infusion syndrome should be considered in unexplained metabolic acidosis, ecg changes, and rhabdomyolysis, and continuous. A rare but potentially fatal reaction continued the common priming factor for pris is critical illness itself. Currently, there are no published case reports of pris occurring in association with tiva.
Another recently described rare, but serious, side effect is propofol infusion syndrome. Features of the syndrome are acute refractory bradycardia leading to asystole in addition to at least one of the following. David hatch1 comments on the controversy surrounding the use of propofol for the sedation of children in intensive care. Risk factors high doses of 4mgkghr or 67 mcgkgmin long duration 48 hrs younger age pris first recognized in pediatric population critical illness. In this article, the authors present factors contributing to the socalled propofol infusion syndrome2 in a. The presentation based on propofol infusion syndrome nehooi will loh, mbbs edic frca fficm priya nair, mbbs frca fficm contin educ anaesth crit care pain 20 6. The clinical features of propofol infusion syndrome pris are acute refractory bradycardia leading to asystole, in the presence of one or more of the following. Propofol diprivan is an intravenous sedative hypnotic that is used in the induction and maintenance of anesthesia and sedation. Use of propofol injectable emulsion infusions for both adult and pediatric icu sedation has been associated with a constellation of metabolic derangements and organ system failures, referred to as propofol infusion syndrome, that have resulted in death. Monitor for propofol infusion syndrome severe metabolic acidosis, hyperkalemia, lipemia, rhabdomyolysis, hepatomegaly, cardiac and renal failure. Propofol related infusion syndrome pris is a rare and controversial clinical entity that was described in patients who got this sedative drug for long periods of. Certain risk factors for the development of propofol infusion syndrome are described, such as appropriate propofol doses and durations of administration, carbohydrate depletion, severe illness, and concomitant administration of catecholamines and glucocorticosteroids. Propofol related infusion syndrome continued from page 20 this may also partially explain some of the cardiac symptoms described in some of the case reports.
Although previous reports have described severe metabolic acidosis during propofol infusion in children, cases have been described in adult patients more recently 3, 4, 68, 10, 23. Although pris is rare, it is frequently fatal if not identified early. The term prispropofol infusion syndromewas originally coined by bray in 1998 to describe the. A case of propofol infusion syndrome in a patient with respiratory failure and sepsis is reported. Since then there have been many case reports and case series, letters in the literature but the aetiology and incidence of pris remains uncertain. The propofol infusion syndrome has been reported in a young patient with traumatic brain injury, which is a susceptibility factor, as high doses are often required to achieve a satisfactory degree of sedation andor to control raised intracerebral pressure 48 a. In 1998, bray proposed the term propofol infusion syndrome pris to describe this clinical state associated with propofol infusions in children. One serious adverse event is propofol related infusion syndrome or propofol infusion syndrome pris, a constellation of signs and symptoms, including bradycardia, metabolic acidosis, liver. Though propofol infusion syndrome results from a larger dose of infusion over a longer period of time, we observed its development even when. Propofol infusion syndrome resuscitation with extracorporeal life support. Clinical pharmacokinetics and pharmacodynamics of propofol.
939 797 1605 474 365 1458 1068 1513 368 1177 1459 309 80 173 426 438 391 696 1176 1303 8 1382 1525 940 403 1102 1214 598 1293 527 595 691 368 1314 934 178 339 1132